The short version
If you’re looking for a real Mounjaro review — not a sponsored post, not a before-and-after ad — you’re in the right place. I’m an ER physician who injected myself every week for six months and kept notes.
– 238 lbs → 212 lbs (108kg → 96kg): 26 lbs (12kg) lost over 6 months
– Burping, nausea, unpredictable appetite — side effects, unfiltered
– Who should use it. Who probably shouldn’t.
Table of Contents
Why I decided to try it myself
Working as an emergency physician on rotating shifts means irregular meals are the norm. Night shifts in particular wore me down — the stress eating, the vending machine runs at 3 a.m., the complete collapse of any routine I tried to build. Back in school I played soccer, swam, cycled. I was fit. Residency took all of that away.
I knew exactly what excess weight was doing to my body. I’m a doctor — I’ve counseled patients on this a hundred times. And yet I kept failing at it myself. Every time my shift pattern changed, whatever diet or exercise routine I had going would fall apart within a week.
Eventually my BMI crossed 30. My old lumbar disc herniation flared back up, and the lower back pain and leg numbness became daily background noise. Around that time, Mounjaro launched in Korea. I’d tried Saxenda before with essentially zero results. So I made a decision: before I ever recommend this to a patient, I need to know what it actually feels like.
What is Mounjaro? — The science behind it
Mounjaro (generic name: tirzepatide) is not just another GLP-1 drug. Unlike semaglutide-based medications like Ozempic or Wegovy, tirzepatide is a dual GIP/GLP-1 receptor agonist — meaning it activates two separate hormonal pathways simultaneously.
GLP-1 (glucagon-like peptide-1) is released from the small intestine after eating. It stimulates insulin secretion, slows gastric emptying, and signals the brain’s satiety center to suppress appetite.
GIP (glucose-dependent insulinotropic polypeptide) also supports insulin release, but crucially, it acts on the brain’s reward circuitry — reducing the drive to eat, not just the ability to keep eating.
Because both receptors are targeted at once, tirzepatide consistently outperforms GLP-1 monotherapy in clinical trials. In the SURMOUNT-1 trial, participants lost an average of over 20% of their body weight over 72 weeks. Your results, as always, may vary.
6-month weight timeline
Starting weight: 238 lbs (108kg).
Month 1 (2.5mg) — -4 lbs (-2kg) → 234 lbs (106kg)
The 2.5mg starting dose isn’t about results — it’s about letting your body adjust. I noticed my appetite was slightly muted, but nothing dramatic happened. I treated it as an adaptation phase and kept my expectations low.
Months 2–3 (5mg) — -18 lbs (-8kg) → 216 lbs (98kg)
Stepping up to 5mg is where things got real. I was dropping roughly 2 lbs (about 1kg) per week. This was the sweet spot — the period where Mounjaro’s effects were most noticeable. My portion sizes shrank naturally, and the late-night snacking habit I’d had for years just… stopped. The pull toward food felt genuinely weaker.
Months 4–6 (5mg) — -4 lbs (-2kg) → 212 lbs (96kg)
The plateau hit. Weight loss slowed to roughly 1–2 lbs (0.5–1kg) per month. Frustrating at first — but entirely predictable. As body weight decreases, basal metabolic rate drops in parallel, and the body works to defend its new set point. A plateau isn’t failure. It’s adaptation.
Side effects, honestly
Positive-only reviews don’t help anyone. Here’s what I actually experienced.
① Frequent burping.
Mounjaro slows gastric emptying, which causes gas to build up in the GI tract. It came out as burping — a lot of it. Not painful, just embarrassing. (Nothing like mid-consultation burping to test your professional composure.) It improved significantly after the first few weeks.
② Nausea after overeating.
Pre-Mounjaro, I could push through fullness without much consequence. Post-Mounjaro, crossing the line into “too much” triggered immediate nausea. Annoying at first — but it turned out to be a remarkably effective built-in brake. I started actually listening to my stomach for the first time in years.
③ Appetite suppression is real, but not total.
A lot of reviews claim hunger disappears completely. Mine didn’t. Overall it was reduced, but on high-stress days and post-night-shift mornings, cravings came back hard. GIP’s effect on the brain’s reward circuitry seems to weaken under conditions of sleep deprivation and acute stress. Mounjaro is a powerful tool. It’s not a switch.
My medical assessment — Who should use it?
I’d recommend it for:
- BMI ≥ 30, or BMI ≥ 27 with obesity-related comorbidities (hypertension, type 2 diabetes, dyslipidemia)
- People who have genuinely tried diet and exercise and aren’t seeing results
- Patients whose quality of life is being impacted — joint pain, sleep apnea, mobility issues
I’d recommend caution for:
- Anyone who is pregnant or planning to become pregnant
- Personal or family history of medullary thyroid carcinoma or MEN2 syndrome
- History of pancreatitis
- People at a healthy weight seeking purely cosmetic results
And yes — get a prescription from an actual physician. That sounds obvious, but the rise of online weight-loss clinics and unmonitored telehealth prescriptions makes it worth saying plainly. Having a doctor who knows your full picture isn’t just a formality.
Why starting matters — and why I’m stopping
Twenty-six pounds in six months. The number looks clean, but the process wasn’t. I didn’t follow a perfect diet. I had bad weeks. I hit plateaus that felt permanent.
What I can say with confidence is this: obesity is a chronic disease, not a character flaw. Mounjaro is a treatment tool — a good one. But it doesn’t work in isolation. Lean on it completely while abandoning diet and exercise, and you’re leaving most of the benefit on the table.
Six months in, with results plateauing, I’m now tapering off. My plan is to step back down to 2.5mg for approximately four weeks before stopping.
From a pharmacology standpoint, tirzepatide has a half-life of roughly five days (120 hours), meaning it takes about 30 days to fully clear the system. Some argue that stopping cold turkey from 5mg is effectively an auto-taper — and they’re not wrong.
But I chose a stepdown for reasons that are less about pharmacokinetics and more about psychology and habit formation. The same way a sudden shift change can throw off your entire daily rhythm, an abrupt stop risks destabilizing the eating patterns I’ve been quietly building for months. I want a slow goodbye — enough time for both body and mind to prepare.
I’d be lying if I said I wasn’t worried about rebound. The SURMOUNT-4 trial showed that participants who discontinued tirzepatide regained roughly two-thirds of their lost weight within a year. That data is real, and it’s why what you build in terms of habits has to outlast the drug.
On that note — the habits I’ve been working on alongside the medication.
Time and mental bandwidth are both still in short supply as an ER doc on rotating shifts. An hour at the gym simply isn’t realistic on most days. So I chose something different: air bike Tabata intervals.
The protocol is simple. 20 seconds all-out → 10 seconds rest, repeated for 8 rounds. Four minutes of actual work. Fifteen minutes including warm-up and cool-down. This format was developed by Japanese researcher Dr. Izumi Tabata in the 1990s and has been shown to deliver simultaneous aerobic and anaerobic adaptations in a fraction of the time of conventional cardio. It also produces a significant EPOC (excess post-exercise oxygen consumption) effect — meaning your metabolism stays elevated for hours after you stop. Three times a week. That’s the plan.
Four minutes doesn’t sound like much — until you’ve actually maxed out on an air bike. Then it sounds exactly right.
I’ll post a follow-up when I’m off the medication completely. The honest version, as always.
📚 References
– Jastreboff AM, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” N Engl J Med. 2022.
📌 More medical articles → View all Medicine posts
답글 남기기